本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

14.92
-0.3800-2.48%
盘后:14.75-0.1700-1.14%18:13 EDT
成交量:530.62万
成交额:7,912.06万
市值:14.67亿
市盈率:-2.56
高:15.39
开:15.27
低:14.69
收:15.30
52周最高:39.89
52周最低:12.73
股本:9,831.72万
流通股本:8,071.56万
量比:1.38
换手率:6.57%
股息:- -
股息率:- -
每股收益(TTM):-5.8279
每股收益(LYR):-5.8316
净资产收益率:-608.47%
总资产收益率:-24.22%
市净率:-5.04
市盈率(LYR):-2.56

数据加载中...

2021/05/07

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/04/16

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

重要事件披露

8-K - Current report
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2021/01/08

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/07

重要事件披露

8-K - Current report